Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Belder

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|July 18, 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandMarion M Mafham, Enti Spata, Raphael Goldacre, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Journal of the American College of Cardiology|October 25, 2011
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) RegistryNeil E Moat, Peter Ludman, Mark A de Belder, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|January 31, 2026
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation studyFlorian A Wenzl, Kok Weng Ow, Matthijs A Velders, et al.
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Circulation. Cardiovascular Interventions|April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA TrialSripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Circulation|September 1, 2020
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA TrialRenato D Lopes, Karen P Alexander, Susanna R Stevens, et al.
American Heart Journal|February 12, 2022
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trialMandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The Lancet. Digital Health|October 17, 2025
Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countriesFlorian A Wenzl, Klaus F Kofoed, Moa Simonsson, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|July 18, 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandMarion M Mafham, Enti Spata, Raphael Goldacre, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Journal of the American College of Cardiology|October 25, 2011
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) RegistryNeil E Moat, Peter Ludman, Mark A de Belder, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|January 31, 2026
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation studyFlorian A Wenzl, Kok Weng Ow, Matthijs A Velders, et al.
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Circulation. Cardiovascular Interventions|April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA TrialSripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Circulation|September 1, 2020
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA TrialRenato D Lopes, Karen P Alexander, Susanna R Stevens, et al.
American Heart Journal|February 12, 2022
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trialMandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The Lancet. Digital Health|October 17, 2025
Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countriesFlorian A Wenzl, Klaus F Kofoed, Moa Simonsson, et al.
Pageof 18